Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China · Delayed Price · Currency is CNY 10.61
-0.12 (-1.12%)
Aug 14, 2026, 3:04 PM CST
SHE:002399 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 5,416 | 5,479 | 5,281 | 5,431 | 7,159 | 6,365 |
Revenue Growth | 2.15% | 3.75% | -2.77% | -24.14% | 12.48% | 19.38% |
Gross Profit Gross Profit Growth | 1,780 | 1,706 | 1,749 | 940.9 | 2,298 | 1,998 |
Operating Income Operating Income Growth | 612.02 | 567.25 | 732.91 | -217.29 | 998.55 | 833.53 |
Net Income Net Income Growth | 380.47 | 349.49 | 646.74 | -783.26 | 727.43 | 240.79 |
Earnings Per Share EPS Growth | 0.26 | 0.24 | 0.44 | -0.53 | 0.50 | 0.16 |
EPS Growth | -41.31% | -45.96% | - | - | 201.95% | -78.32% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Preparations Preparations Growth | 7,702 |
Active Pharmaceutical Ingredient (API) Active Pharmaceutical Ingredient (API) Growth | 3,203 |
CDMO CDMO Growth | 1,033 |
Others Others Growth | 277.99 |
Intersegment offset Intersegment offset Growth | -6,737 |
Total Total Growth | 5,479 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 3,505 | 2,830 | 2,557 | 2,386 | 3,450 | 3,925 |
Total Debt Total Debt Growth | 3,263 | 2,974 | 3,545 | 5,563 | 6,464 | 5,654 |
Net Cash (Debt) Net Cash Growth | 241.91 | -143.41 | -987.34 | -3,177 | -3,013 | -1,729 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.16 | -0.10 | -0.67 | -2.15 | -2.05 | -1.18 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,546 | 1,713 | 2,194 | 398.22 | -756.61 | -6.63 |
Capital Expenditures CapEx Growth | -101.23 | -121.1 | -202.77 | -437.43 | -222.42 | -193.86 |
Free Cash Flow Free Cash Flow Growth | 1,444 | 1,592 | 1,991 | -39.22 | -979.03 | -200.49 |
Free Cash Flow Growth | -13.73% | -20.06% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 32.87% | 31.15% | 33.11% | 17.32% | 32.10% | 31.39% |
Operating Margin | 11.30% | 10.35% | 13.88% | -4.00% | 13.95% | 13.10% |
Pretax Margin | 7.97% | 7.34% | 13.75% | -17.09% | 11.59% | 3.49% |
Profit Margin | 7.03% | 6.38% | 12.25% | -14.42% | 10.16% | 3.78% |
FCF Margin | 26.67% | 29.05% | 37.71% | -0.72% | -13.68% | -3.15% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.145 | 0.145 | 0.250 | - | 0.100 | 0.035 |
Dividend Per Share Growth | -42.00% | -42.00% | - | - | 185.71% | -76.67% |
Dividend Yield | 1.37% | 1.25% | 2.43% | - | 0.81% | 0.21% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 40.92 | 45.02 | 21.88 | - | 23.49 | 94.63 |
Forward PE | 18.29 | 18.64 | 20.66 | 24.06 | 14.64 | 31.09 |
P/FCF Ratio | 9.75 | 9.89 | 7.11 | - | - | - |
PS Ratio | 2.60 | 2.87 | 2.68 | 2.83 | 2.39 | 3.58 |